Low dose oral administration of 4-demethoxy-daunorubicin (idarubicin) in advanced cancer patients

Related Papers

• Action mechanism of idarubicin (4-demethoxydaunorubicin) as compared with daunorubicin in leukemic cells.(1993)
• → Idarubicin appears equivalent to dose-intense daunorubicin for remission induction in patients with acute myeloid leukemia(2013)14 cited
• → Comparison of the intracellular pharmacokinetics of daunorubicin and idarubicin in patients with acute leukemia(1994)25 cited
• Comparative evaluation of the intracellular accumulation and DNA binding of idarubicin and daunorubicin in sensitive and multidrug-resistant human leukaemia K562 cells.(1996)
• Comparing the Clinical Results of Idarubicin and Daunorubicin in Treating AML(2008)